Screening of the Metastasis-Associated Genes by Gene Chip in High Metastatic Human Ovarian Cancer Cell Lines

Shenhua Xu; Hangzhou Mou; Linhuei Gu; Dan Su; Chihong Zhu; Xianglin Liu

doi:10.1016/S1673-8527(07)60066-6

Volume 34 Issue 7

Jul. 2007

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2007 > 34(7): 581-590

PDF( 812 KB)

Screening of the Metastasis-Associated Genes by Gene Chip in High Metastatic Human Ovarian Cancer Cell Lines

doi: 10.1016/S1673-8527(07)60066-6

Zhejiang Cancer Research Institute, Hangzhou 310022, China

More Information

Corresponding author: E-mail address: shenhuaxu@hotmail.com (Shenhua Xu)
Received Date: 2006-07-18
Accepted Date: 2006-12-04

Available Online: 2007-07-20

Publish Date: 2007-07-20

Abstract

Abstract

Affymetrix U133A oligonucleotide microarrays were used to study the differences of gene expressions between high (H) metastatic ovarian cancer cell line, HO-8910PM, and normal ovarian tissues (C), bioinformatics was used to identify their chromosomal localizations. A total of 1,237 genes were found to have a difference in expression levels more than eight times. Among them 597 were upregulated (Signal Log Ratio[SLR] ≥ 3), and 640 genes were downregulated (SLR≤3). Except one gene, whose location was unknown, all these genes were randomly distributed on all the chromosomes. However, chromosome 1 contained the most differentially expressed genes (115 genes, 9.3%), followed by chromosome 2 (94 genes, 7.6%), chromosome 12 (88 genes, 7.1%), chromosome 11 (76 genes, 6.1%), chromosomes X (71 genes, 5.7%), and chromosomes17 (69 genes, 5.6%). These genes were localized on short-arm of chromosome (q), which had 805 (65.1%) genes, and the short arms of No.13, 14, 15, 21, and 22 chromosomes were the only parts of the chromosomes where the differentially expressed genes were localized. Functional classification showed that most of the genes (306 genes, 24.7%) belonged to the enzymes and their regulator groups. The subsequent group was the nucleic acid binding genes (144 genes, 11.6%). The rest of the top two groups were signal transduction genes (137 genes, 11.1%) and proteins binding genes (116 genes, 9.4%). These comprised 56.8% of all the differentially expressed genes. There were also 207 genes whose functions were unknown (16.7 %). Therefore it was concluded that differentially expressed genes in high metastatic ovarian cancer cell were supposed to be randomly distributed across the genome, but the majority were found on chromosomes 1, 2, 12, 11, 17, and X. Abnormality in four groups of genes, including in enzyme and its regulator, nucleic acid binding, signal transduction and protein binding associated genes, might play important roles in ovarian cancer metastasis. Those genes need to be further studied.
- ovarian cancer cell line,
- metastatic associated gene,
- chromosomal localization,
- molecular function

FullText(HTML)

References(23)

References

[1]	Wang, K, Gan, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray Gene, 229 (1999),pp. 101-108
[2]	Macleod, K, Mullen, et al. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer Cancer Res, 65 (2005),pp. 6789-6800
[3]	Sawiris, GP, Sherman-Baust, et al. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer Cancer Res, 62 (2002),pp. 2923-2928
[4]	Zhang, X, Feng, et al. Characterization of differentially expressed genes in ovarian cancer by cDNA microarrays Int J Gynecol Cancer, 15 (2005),pp. 50-57
[5]	Zhang, JQ, Wang, et al. Differentially expressed genes in human giant cell lung cancer lines with different metastatic potentials Chin J Oncol, 26 (2004),pp. 590-593
[6]	Wu, X, Jia, et al. Comparative study on gene expression difference between high and low metastatic human hepatocell carcinoma cell strains China Oncology, 13 (2003),pp. 97-101
[7]	Wang, JH, Chen, et al. Screening and identification of gastric adenocarcinoma metastasis related genes by using cDNA microarray coupled to FDD-PCR Acta Biochimica et Bbiophysica Sinica, 34 (2002),pp. 475-481
[8]	Ye, LH, You, et al. Screening metastasis-associated genes in breast cancer cells with different matastatic ability by cDNA microarray Progress In Biochemistry and Biophysics, 32 (2005),pp. 421-428
[9]	Xu, SH, Qiang, et al. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization J Exp Clin Cancer Res, 18 (1999),pp. 233-239
[10]	Peng, XL, Yuan, et al. Experimental technique of gene engineering Hunan Science & Technique Issue Agency Second (1998),pp. 197-199
[11]	Sahin, I, Yilmaz, et al. Cytogenetic abnormalities in serous papillary adenocarcinoma of the ovary Eur J Gynaecol Oncol, 25 (2004),pp. 585-586
[12]	Lambros, MB, Fiegler, et al. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization J Pathol, 205 (2005),pp. 29-40
[13]	Fishman, A, Shalom-Paz, et al. Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization Int J Gynecol Cancer, 15 (2005),pp. 261-266
[14]	Urzua, U, Frankenberger, et al. Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas Tumour Biol, 26 (2005),pp. 236-244
[15]	Yu, CD, Xu, et al. Gene expression profiles differences in gastric carcinoma, pericancerous epithelium and normal gastric mucosa by gene chip World J Gastroenterol, 11 (2005),pp. 2390-2397
[16]	Xu, SH, Mou, et al. Study of the gene expression profile of human ovarian carcinoma by a gene chip Chinese Journal of Clinical Oncology, 2 (2005),pp. 662-670
[17]	Xu, SH, Feng, et al. Expression of multi-gene producetion in highly metastasizing human ovarian cancer cell line by flow cytometry Chin J Obstet Gynecol, 35 (2000),pp. 565-566
[18]	Abraham, R, Schafer, et al. Identification of MMP-15 as an anti-Apoptotic factor in cancer cells J Biol Chem, 280 (2005),pp. 34123-34132
[19]	Nicholson, BE, Frierson, et al. Profiling the evolution of human metastatic bladder cancer Cancer Res, 64 (2004),pp. 7813-7821
[20]	Minn, AJ, Gupta, et al. Genes that mediate breast cancer metastasis to lung Nature, 436 (2005),pp. 518-524
[21]	Fukui, R, Nishimori, et al. Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer J Surg Res, 129 (2005),pp. 94-100
[22]	Ni, XH, Xu, et al. A study of multi-gene expression in highly metastasizing human ovarian cancer cell line HO-8910PM and its mother cell line HO-8910 The Practical J of Cancer, 14 (1999),pp. 18-20
[23]	Ba, WL, Li, et al. The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma J Clin Otorhinolaryngol, 120 (2006),pp. 254-257